Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference3 articles.
1. Guideline on good pharmacovigilance practices (GVP). Module VI – collection, management and submission of reports of suspected adverse reactions to medicinal products (Rev 2). 28 July 2017. EMA/873138/2011; 2017.
2. Cammarata SM . Criticità ed opportunità degli usi off-label dei medicinali. 2019. Available: https://flore.unifi.it/handle/2158/1151461?mode=complete
3. Systematic data monitoring and analysis of cardiovascular off-label prescriptions in pediatrics: focus on angiotensin-converting enzyme inhibitors (ACE-I) and beta blockers;Cammarata;High Blood Press Cardiovasc Prev,2022